-- 日立（東京證券交易所代號：6501）2025財年歸屬於母公司股東的淨利年增30%，達到8,023億日圓，上年同期為6,157億日圓。 該公司為電力和再生能源企業提供系統解決方案。根據週一提交給東京證券交易所的文件顯示，其每股淨利潤從上年同期的133.72日圓增至176.63日圓。 截至3月31日的整個財年，日立的營收年增8%，達到10.6兆日圓，而上年同期為9.783兆日圓。 在另一份揭露文件中，日立計畫根據獲利表現和其他因素，派發每股27日圓的年終股利。 總額約1,215億日圓的股利預計將於5月由董事會最終確定，並將於6月4日支付。 公司預計2026財年淨利為8,500億日元，營業收入為11.1兆日圓。 日立計畫在本財年派發每股28日圓的期中股利。
Related Articles
Asia
Dongjiang Environmental's Loss Widens 2.7% in Q1
Dongjiang Environmental (HKG:0895, SHE:002672) recorded an attributable loss of 150.2 million yuan in the first quarter of 2026, 2.7% wider than 146.3 million yuan a year prior, according to a Monday Hong Kong bourse filing.Loss per share widened to 0.14 yuan from 0.13 yuan in the corresponding period of the previous fiscal year.The waste disposal management company's revenue from operations declined 13% to 602.6 million yuan from 695.9 million yuan in the year-ago period.
$HKG:0895$SHE:002672
Sectors
Sector Update: Health Care Stocks Edge Higher Pre-Bell Monday
Health care stocks were edging higher pre-bell Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.2% and the iShares Biotechnology ETF (IBB) marginally advancing.Organon (OGN) has agreed to be acquired by Sun Pharmaceutical Industries for $14 per share in an all-cash deal with an $11.75 billion enterprise valuation, the companies said. Shares of Organon were up more than 17% premarket.Oruka Therapeutics (ORKA) stock was up more than 34% after the company said 63.5% of patients treated with ORKA-001 achieved the primary endpoint of complete skin clearance at week 16 in a phase 2a trial in moderate-to-severe plaque psoriasis.Ligand Pharmaceuticals (LGND) shares were up more than 3% after the company said it has agreed to purchase biotechnology peer Xoma Royalty (XOMA) in an all-cash deal valued at roughly $739 million.
$IBB$LGND$OGN$ORKA$XLV$XOMA
Asia
Zuoli Kechuang Logs Drop in Q1 Profit
Zuoli Kechuang Micro-finance Company (HKG:6866) recorded a decline in attributable profit in the first quarter of 2026 to 13.6 million yuan from 14.8 million yuan a year prior, according to a Monday Hong Kong bourse filing.Net interest income for the three months slipped to 28.4 million yuan from 35.2 million yuan in the year-ago period.
$HKG:6866